Apoquel

Authorised

This medicine is authorised for use in the European Union

oclacitinib maleate

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Apoquel : EPAR - Summary for the public

Product information

Apoquel : EPAR - Product Information

Apoquel : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Apoquel
• Active substance:
  oclacitinib maleate
• International non-proprietary name (INN) or common name:
  oclacitinib maleate

Pharmacotherapeutic group

Agents for dermatitis, excluding corticosteroids

Authorisation details

• EMA product number:
  EMEA/V/C/002688

Assessment history

Changes since initial authorisation of medicine

Apoquel : EPAR - Procedural steps taken and scientific information after authorisation

Apoquel-V-C-002688-X-0019 : EPAR - Assessment report - Variation

Adopted

CVMP post-authorisation summary of positive opinion for Apoquel (II-0019)

Adopted Reference Number: EMA/CVMP/523501/2021

Initial marketing authorisation documents

Apoquel : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Apoquel

Adopted Reference Number: EMA/CVMP/322909/2013